Frontiers in cellular and infection microbiology · 2026
Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical Nocardia isolates: a membrane-targeting approach to combat persistent infections.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wei Ming, Xie Shiwang, Wang Peng, Li Tianmeng, Liu Jun, Yang Jingxian, Xu Xinmin, Luo Dan, Gu Li, Wang Shuai
Аннотация
BACKGROUND: Conventional antibiotics against slow-growing, mycolic acid-rich Nocardia often require prolonged therapy and are associated with high relapse rates. Membrane-targeting essential fatty acids may circumvent growth-dependent resistance.
METHODS: Five essential fatty acids were screened against 82 clinical Nocardia isolates by broth microdilution. Docosahexaenoic acid (DHA) was further assessed for bactericidal kinetics, membrane integrity by propidium iodide staining and scanning electron microscopy, transcriptomic profiling, and combined activity with amikacin and tobramycin.
RESULTS: α-Linolenic acid, γ-linolenic acid, eicosapentaenoic acid and DHA exhibited comparable activity (MIC50/MIC90: 31.25/62.50 μM), corresponding to mass concentration ranges of 8.7 to 10.3 μg/mL for MIC50 and 17.4 to 20.6 μg/mL for MIC90. However, arachidonic acid was markedly less active. DHA rapidly disrupted the Nocardia cell envelope, causing propidium iodide influx and ultrastructural damage, and achieved concentration-dependent bactericidal killing within 1 h, a feat not observed with imipenem. Transcriptomic analysis of the surviving subpopulation revealed downregulation of the proton-pumping Nuo complex, upregulation of type II NADH dehydrogenase (Ndh), and global induction of translation machinery. These transcriptional changes, together with pre-existing membrane damage, additively enhanced the activity of amikacin against intrinsically resistant N. wallacei (FICI, 0.51-0.56).
CONCLUSIONS: These findings demonstrate that DHA displays rapid membrane-disruptive activity and can enhance amikacin activity against Nocardia under the defined in vitro conditions.
METHODS: Five essential fatty acids were screened against 82 clinical Nocardia isolates by broth microdilution. Docosahexaenoic acid (DHA) was further assessed for bactericidal kinetics, membrane integrity by propidium iodide staining and scanning electron microscopy, transcriptomic profiling, and combined activity with amikacin and tobramycin.
RESULTS: α-Linolenic acid, γ-linolenic acid, eicosapentaenoic acid and DHA exhibited comparable activity (MIC50/MIC90: 31.25/62.50 μM), corresponding to mass concentration ranges of 8.7 to 10.3 μg/mL for MIC50 and 17.4 to 20.6 μg/mL for MIC90. However, arachidonic acid was markedly less active. DHA rapidly disrupted the Nocardia cell envelope, causing propidium iodide influx and ultrastructural damage, and achieved concentration-dependent bactericidal killing within 1 h, a feat not observed with imipenem. Transcriptomic analysis of the surviving subpopulation revealed downregulation of the proton-pumping Nuo complex, upregulation of type II NADH dehydrogenase (Ndh), and global induction of translation machinery. These transcriptional changes, together with pre-existing membrane damage, additively enhanced the activity of amikacin against intrinsically resistant N. wallacei (FICI, 0.51-0.56).
CONCLUSIONS: These findings demonstrate that DHA displays rapid membrane-disruptive activity and can enhance amikacin activity against Nocardia under the defined in vitro conditions.